The opportunities are now so large, I can’t see how it makes sense for RAC not to partner/raise/giveaway Some IP in the pursuit of these.
So much has changed from the original strategy of being a small Australian biotech trying to stay under the radar, and trying to run off fumes,
I feel like management are now out of their depth with the opportunities available and if they don’t announce more collaboration soon the head start will quickly shorten.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.22 |
Change
0.000(0.00%) |
Mkt cap ! $212.8M | |||
| Open | High | Low | Value | Volume |
| $1.24 | $1.26 | $1.22 | $57.47K | 46.25K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4163 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 423 | 1 |
View Market Depth
| Last trade - 11.51am 25/06/2025 (20 minute delay) ? |
| RAC (ASX) Chart |